{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:38:55Z","timestamp":1794490735784,"version":"4.9.1"},"reference-count":304,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02415-6","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:47:29Z","timestamp":1759754849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["MALAT1 as a molecular driver of tumor progression, immune evasion, and resistance to therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Amirreza","family":"Bitaraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Zafarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardis","family":"Jahandideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyamin","family":"Hakak-Zargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atousa","family":"Haghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golareh","family":"Asgaritarghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Babashah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"7414","key":"2415_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101\u20138.","journal-title":"Nature"},{"issue":"5","key":"2415_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tig.2015.03.007","volume":"31","author":"GS Laurent","year":"2015","unstructured":"Laurent GS, Wahlestedt C, Kapranov P. The landscape of long noncoding RNA classification. Trends Genet. 2015;31(5):239\u201351.","journal-title":"Trends Genet"},{"issue":"2","key":"2415_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cac2.12254","volume":"42","author":"ZT Yao","year":"2022","unstructured":"Yao ZT, Yang YM, Sun MM, He Y, Liao L, Chen KS, et al. New insights into the interplay between long non\u2010coding RNAs and RNA\u2010binding proteins in cancer. Cancer Commun. 2022;42(2):117\u201340.","journal-title":"Cancer Commun"},{"issue":"6","key":"2415_CR4","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.cell.2013.02.016","volume":"152","author":"JT Lee","year":"2013","unstructured":"Lee JT, Bartolomei MS. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell. 2013;152(6):1308\u201323.","journal-title":"Cell"},{"issue":"1","key":"2415_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01159-9","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X, Liu M, Li M, Zhang S, Hiju H, Sun J, et al. Epigenetic modulations of noncoding RNA: a novel dimension of cancer biology. Mol Cancer. 2020;19(1):1\u201312.","journal-title":"Mol Cancer"},{"issue":"5","key":"2415_CR6","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/nar\/gky095","volume":"46","author":"N Romero-Barrios","year":"2018","unstructured":"Romero-Barrios N, Legascue MF, Benhamed M, Ariel F, Crespi M. Splicing regulation by long noncoding RNAs. Nucleic Acids Res. 2018;46(5):2169\u201384.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2415_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cell.2017.06.020","volume":"170","author":"CM Roake","year":"2017","unstructured":"Roake CM, Artandi SE. Approaching TERRA Firma: genomic functions of telomeric noncoding RNA. Cell. 2017;170(1):8\u20139.","journal-title":"Cell"},{"issue":"2","key":"2415_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2415_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2415_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393\u2013407.","journal-title":"Cell"},{"issue":"4","key":"2415_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040579","volume":"17","author":"\u00c9 M\u00e1rton","year":"2025","unstructured":"M\u00e1rton \u00c9, Varga A, Domoszlai D, Bugly\u00f3 G, Bal\u00e1zs A, Penyige A, et al. Non-coding RNAs in cancer: structure, function, and clinical application. Cancers (Basel). 2025;17(4): 579.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2415_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0734-6","volume":"3","author":"J Carlevaro-Fita","year":"2020","unstructured":"Carlevaro-Fita J, Lanz\u00f3s A, Feuerbach L, Hong C, Mas-Ponte D, Pedersen JS, et al. Cancer LncRNA census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Commun Biolo. 2020;3(1):1\u201316.","journal-title":"Commun Biolo"},{"issue":"39","key":"2415_CR13","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","volume":"22","author":"P Ji","year":"2003","unstructured":"Ji P, Diederichs S, Wang W, B\u00f6ing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin \u03b2 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031\u201341.","journal-title":"Oncogene"},{"issue":"2","key":"2415_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cancers11020216","volume":"11","author":"Y Sun","year":"2019","unstructured":"Sun Y, Ma L. New insights into long non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel). 2019;11(2):216.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2415_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tig.2017.11.005","volume":"34","author":"Q Sun","year":"2018","unstructured":"Sun Q, Hao Q, Prasanth KV. Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 2018;34(2):142\u201357.","journal-title":"Trends Genet"},{"issue":"6","key":"2415_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.molcel.2010.08.011","volume":"39","author":"V Tripathi","year":"2010","unstructured":"Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925\u201338.","journal-title":"Mol Cell"},{"issue":"2","key":"2415_CR17","first-page":"22","volume":"6","author":"G Arun","year":"2020","unstructured":"Arun G, Aggarwal D, Spector DL. MALAT1 long non-coding RNA: functional implications. Noncoding RNA. 2020;6(2): 22.","journal-title":"Noncoding RNA"},{"key":"2415_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2164-8-39","volume":"8","author":"JN Hutchinson","year":"2007","unstructured":"Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007;8: 39.","journal-title":"BMC Genomics"},{"issue":"18","key":"2415_CR19","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/emboj.2010.199","volume":"29","author":"D Bernard","year":"2010","unstructured":"Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan Z, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 2010;29(18):3082\u201393.","journal-title":"EMBO J"},{"issue":"5","key":"2415_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cell.2008.10.012","volume":"135","author":"JE Wilusz","year":"2008","unstructured":"Wilusz JE, Freier SM, Spector DL. 3\u2019 end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell. 2008;135(5):919\u201332.","journal-title":"Cell"},{"issue":"6","key":"2415_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molcel.2009.01.026","volume":"33","author":"CM Clemson","year":"2009","unstructured":"Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009;33(6):717\u201326.","journal-title":"Mol Cell"},{"issue":"7","key":"2415_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nsmb.2844","volume":"21","author":"JA Brown","year":"2014","unstructured":"Brown JA, Bulkley D, Wang J, Valenstein ML, Yario TA, Steitz TA, et al. Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nat Struct Mol Biol. 2014;21(7):633\u201340.","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"2415_CR23","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41594-024-01340-4","volume":"31","author":"I Skeparnias","year":"2024","unstructured":"Skeparnias I, Bou-Nader C, Anastasakis DG, Fan L, Wang YX, Hafner M, et al. Structural basis of MALAT1 RNA maturation and mascRNA biogenesis. Nat Struct Mol Biol. 2024;31(11):1655\u201368.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"2415_CR24","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1093\/nar\/gkw047","volume":"44","author":"X Zong","year":"2016","unstructured":"Zong X, Nakagawa S, Freier SM, Fei J, Ha T, Prasanth SG, et al. Natural antisense RNA promotes 3\u2019 end processing and maturation of MALAT1 lncRNA. Nucleic Acids Res. 2016;44(6):2898\u2013908.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"2415_CR25","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1016\/j.febslet.2013.07.048","volume":"587","author":"F Yang","year":"2013","unstructured":"Yang F, Yi F, Han X, Du Q, Liang Z. MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Lett. 2013;587(19):3175\u201381.","journal-title":"FEBS Lett"},{"key":"2415_CR26","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S169406","volume":"10","author":"Z-X Li","year":"2018","unstructured":"Li Z-X, Zhu Q-N, Zhang H-B, Hu Y, Wang G, Zhu Y-S. MALAT1: a potential biomarker in cancer. Cancer Manag Res. 2018;10: 6757.","journal-title":"Cancer Manag Res"},{"issue":"7","key":"2415_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00109-013-1028-y","volume":"91","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Diederichs S. MALAT1 \u2013 a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl). 2013;91(7):791\u2013801.","journal-title":"J Mol Med (Berl)"},{"key":"2415_CR28","doi-asserted-by":"crossref","unstructured":"Zhang J, Han C, Song K, Chen W, Ungerleider N, Yao L, et al. The long-noncoding RNA MALAT1 regulates TGF-\u03b2\/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells. PLoS One. 2020;15(1):e0228160.","DOI":"10.1371\/journal.pone.0228160"},{"issue":"2","key":"2415_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/jop.12466","volume":"46","author":"J Liang","year":"2017","unstructured":"Liang J, Liang L, Ouyang K, Li Z, Yi X. MALAT 1 induces tongue cancer cells\u2019 EMT and inhibits apoptosis through Wnt\/\u03b2-catenin signaling pathway. J Oral Pathol Med. 2017;46(2):98\u2013105.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"2415_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.21873\/invivo.11541","volume":"33","author":"CH Hong","year":"2019","unstructured":"Hong CH, Lin SH, Lee CH. CCL21 induces mTOR-dependent MALAT1 expression, leading to cell migration in cutaneous T-cell lymphoma. In Vivo. 2019;33(3):793\u2013800.","journal-title":"In Vivo"},{"issue":"6","key":"2415_CR31","first-page":"5335","volume":"17","author":"K Zhu","year":"2019","unstructured":"Zhu K, Ren Q, Zhao Y. LncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K\/AKT pathway. Oncol Lett. 2019;17(6):5335\u201342.","journal-title":"Oncol Lett"},{"issue":"4","key":"2415_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/genes15040479","volume":"15","author":"K Pi\u00f3rkowska","year":"2024","unstructured":"Pi\u00f3rkowska K, Zygmunt K, Hunter W, Wr\u00f3blewska K. MALAT1: a long non-coding RNA with multiple functions and its role in processes associated with fat deposition. Genes. 2024;15(4): 479.","journal-title":"Genes"},{"issue":"1","key":"2415_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s12864-015-1881-x","volume":"16","author":"XY Ma","year":"2015","unstructured":"Ma XY, Wang JH, Wang JL, Ma CX, Wang XC, Liu FS. Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells. BMC Genomics. 2015;16(1):676.","journal-title":"BMC Genomics"},{"issue":"9","key":"2415_CR34","doi-asserted-by":"publisher","first-page":"e23356","DOI":"10.1371\/journal.pone.0023356","volume":"6","author":"M Lin","year":"2011","unstructured":"Lin M, Pedrosa E, Shah A, Hrabovsky A, Maqbool S, Zheng D, et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS ONE. 2011;6(9): e23356.","journal-title":"PLoS One"},{"issue":"63","key":"2415_CR35","doi-asserted-by":"publisher","first-page":"106648","DOI":"10.18632\/oncotarget.20678","volume":"8","author":"Q Li","year":"2017","unstructured":"Li Q, Pan X, Wang X, Jiao X, Zheng J, Li Z, et al. Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma. Oncotarget. 2017;8(63): 106648.","journal-title":"Oncotarget"},{"issue":"5","key":"2415_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11608","volume":"24","author":"H Zhao","year":"2022","unstructured":"Zhao H, Wang Y, Hou W, Ding X, Wang W. Long non-coding RNA MALAT1 promotes cell proliferation, migration and invasion by targeting miR-590-3p in osteosarcoma. Exp Ther Med. 2022;24(5):1\u20139.","journal-title":"Exp Ther Med"},{"issue":"2","key":"2415_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/cells14020125","volume":"14","author":"SA Fahim","year":"2025","unstructured":"Fahim SA, Ragheb M, Fayed IH, Osama A, Karam A, Magdeldin S, et al. Interaction between Malat1 and miR-499-5p regulates Meis1 expression and function with a net impact on cell proliferation. Cells. 2025;14(2): 125.","journal-title":"Cells"},{"issue":"12","key":"2415_CR38","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1007\/s12033-023-00953-2","volume":"66","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu Y, Qiu G, Luo Y, Bao Y, Lu J, et al. METTL3 mediated MALAT1 m6a modification promotes proliferation and metastasis in osteosarcoma cells. Mol Biotechnol. 2024;66(12):3538\u201348.","journal-title":"Mol Biotechnol"},{"key":"2415_CR39","first-page":"2143","volume":"9","author":"F Xu","year":"2016","unstructured":"Xu F, Zhang Z-q, Fang Y-c, Li X-l, Sun Y, Xiong C-z, et al. Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway. OncoTargets and therapy. 2016;9:2143.","journal-title":"OncoTargets and therapy."},{"issue":"1","key":"2415_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cancers13010015","volume":"13","author":"S Nanni","year":"2020","unstructured":"Nanni S, Aiello A, Salis C, Re A, Cencioni C, Bacci L, et al. Metabolic reprogramming by malat1 depletion in prostate cancer. Cancers. 2020;13(1): 15.","journal-title":"Cancers"},{"issue":"26","key":"2415_CR41","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1016\/j.cell.2024.10.021","volume":"187","author":"WW Liang","year":"2024","unstructured":"Liang WW, M\u00fcller S, Hart SK, Wessels HH, M\u00e9ndez-Mancilla A, Sookdeo A, et al. Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells. Cell. 2024;187(26):7637-54.e29.","journal-title":"Cell"},{"issue":"2","key":"2415_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mc.22919","volume":"58","author":"MA Gordon","year":"2019","unstructured":"Gordon MA, Babbs B, Cochrane DR, Bitler BG, Richer JK. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing. Mol Carcinog. 2019;58(2):196\u2013205.","journal-title":"Mol Carcinog"},{"issue":"12","key":"2415_CR43","first-page":"3703","volume":"22","author":"C Guo","year":"2018","unstructured":"Guo C, Wang X, Chen LP, Li M, Li M, Hu YH, et al. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt\/\u03b2-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(12):3703\u201312.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2415_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/OTT.S431810","volume":"17","author":"J Xiong","year":"2024","unstructured":"Xiong J, Lian W, Zhao R, Gao K. METTL3\/MALAT1\/ELAVL1 axis promotes tumor growth in ovarian cancer. Onco Targets Ther. 2024;17:85\u201397.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"2415_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.devcel.2021.01.015","volume":"56","author":"X Wang","year":"2021","unstructured":"Wang X, Liu C, Zhang S, Yan H, Zhang L, Jiang A, et al. N6-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles. Dev Cell. 2021;56(5):702\u201315 e8.","journal-title":"Dev Cell"},{"issue":"8","key":"2415_CR46","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CAD.0000000000000650","volume":"29","author":"Y Tang","year":"2018","unstructured":"Tang Y, Xiao G, Chen Y, Deng Y. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt\/mTOR signaling. Anticancer Drugs. 2018;29(8):725\u201335.","journal-title":"Anticancer Drugs"},{"issue":"3","key":"2415_CR47","first-page":"375","volume":"22","author":"G Tiansheng","year":"2020","unstructured":"Tiansheng G, Junming H, Xiaoyun W, Peixi C, Shaoshan D, Qianping C. LncRNA metastasis-associated lung adenocarcinoma transcript 1 promotes proliferation and invasion of non-small cell lung cancer cells via down-regulating miR-202 expression. Cell J (Yakhteh). 2020;22(3):375.","journal-title":"Cell J (Yakhteh)"},{"issue":"7","key":"2415_CR48","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1111\/crj.12906","volume":"12","author":"W Chen","year":"2018","unstructured":"Chen W, Zhao W, Chen S, Zhang L, Guo Z, Wang L, et al. Expression and correlation of MALAT1 and SOX9 in non-small cell lung cancer. Clin Respir J. 2018;12(7):2284\u201391.","journal-title":"Clin Respir J"},{"issue":"22","key":"2415_CR49","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1038\/s41388-021-01816-3","volume":"40","author":"M Li","year":"2021","unstructured":"Li M, Shi M, Hu C, Chen B, Li S. MALAT1 modulated FOXP3 ubiquitination then affected GINS1 transcription and drived NSCLC proliferation. Oncogene. 2021;40(22):3870\u201384.","journal-title":"Oncogene"},{"key":"2415_CR50","doi-asserted-by":"publisher","first-page":"610159","DOI":"10.3389\/pore.2021.610159","volume":"27","author":"J Dai","year":"2021","unstructured":"Dai J, Zhou N, Wu R, Du J, Miao S, Gong K, et al. LncRNA MALAT1 regulating lung carcinoma progression via the miR-491\u20135p\/UBE2C axis. Pathol Oncol Res. 2021;27:610159.","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"2415_CR51","first-page":"419","volume":"12","author":"H Xiao","year":"2019","unstructured":"Xiao H, Zhu Q, Zhou J. Long non-coding RNA MALAT1 interaction with miR-429 regulates the proliferation and EMT of lung adenocarcinoma cells through RhoA. Int J Clin Exp Pathol. 2019;12(2):419.","journal-title":"Int J Clin Exp Pathol"},{"key":"2415_CR52","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3389\/fimmu.2018.02327","volume":"9","author":"M Presta","year":"2018","unstructured":"Presta M, Foglio E, Churruca Schuind A, Ronca R. Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2. Front Immunol. 2018;9: 2327.","journal-title":"Front Immunol"},{"key":"2415_CR53","doi-asserted-by":"publisher","first-page":"15972","DOI":"10.1038\/srep15972","volume":"5","author":"X Zhou","year":"2015","unstructured":"Zhou X, Liu S, Cai G, Kong L, Zhang T, Ren Y, et al. Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma. Sci Rep. 2015;5: 15972.","journal-title":"Sci Rep"},{"issue":"10","key":"2415_CR54","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/15384047.2017.1373214","volume":"18","author":"B Shi","year":"2017","unstructured":"Shi B, Wang Y, Yin F. MALAT1\/miR-124\/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells. Cancer Biol Ther. 2017;18(10):792\u2013800.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"2415_CR55","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1002\/jcb.26464","volume":"119","author":"J Huang","year":"2018","unstructured":"Huang J, Yang Y, Fang F, Liu K. MALAT1 modulates the autophagy of retinoblastoma cell through miR-124-mediated stx17 regulation. J Cell Biochem. 2018;119(5):3853\u201363.","journal-title":"J Cell Biochem"},{"issue":"9","key":"2415_CR56","doi-asserted-by":"publisher","first-page":"190095","DOI":"10.1098\/rsob.190095","volume":"9","author":"Z Lu","year":"2019","unstructured":"Lu Z, Luo T, Pang T, Du Z, Yin X, Cui H, et al. MALAT1 promotes gastric adenocarcinoma through the MALAT1\/miR-181a-5p\/AKT3 axis. Open Biol. 2019;9(9): 190095.","journal-title":"Open Biol"},{"key":"2415_CR57","doi-asserted-by":"crossref","unstructured":"Zheng X, Ren J, Peng B, Ye J, Wu X, Zhao W, et al. MALAT1 overexpression promotes the growth of colon cancer by repressing \u03b2-catenin degradation. Cell Signal.\u00a02020;76:109676.","DOI":"10.1016\/j.cellsig.2020.109676"},{"issue":"4","key":"2415_CR58","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/bjc.2014.383","volume":"111","author":"Q Ji","year":"2014","unstructured":"Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ\/PTBP2 complex. Br J Cancer. 2014;111(4):736\u201348.","journal-title":"Br J Cancer"},{"issue":"1","key":"2415_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-03318-8","volume":"12","author":"M Xiong","year":"2021","unstructured":"Xiong M, Wu M, Peng D, Huang W, Chen Z, Ke H, et al. Lncrna DANCR represses doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells. Cell Death Dis. 2021;12(1):1\u201317.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2415_CR60","doi-asserted-by":"publisher","first-page":"20816","DOI":"10.1002\/jcp.28687","volume":"234","author":"D Tang","year":"2019","unstructured":"Tang D, Yang Z, Long F, Luo L, Yang B, Zhu R, et al. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p\/Oct4 axis. J Cell Physiol. 2019;234(11):20816\u201328.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2415_CR61","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s11658-019-0175-8","volume":"24","author":"Y Si","year":"2019","unstructured":"Si Y, Yang Z, Ge Q, Yu L, Yao M, Sun X, et al. Long non-coding RNA Malat1 activated autophagy, hence promoting cell proliferation and inhibiting apoptosis by sponging miR-101 in colorectal cancer. Cell Mol Biol Lett. 2019;24(1):50.","journal-title":"Cell Mol Biol Lett"},{"issue":"11","key":"2415_CR62","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/carcin\/bgab069","volume":"42","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wang M, Mao A, Zhao Y, Wang L, Xu Y, et al. Long noncoding RNA MALAT1 sponging miR-26a-5p to modulate Smad1 contributes to colorectal cancer progression by regulating autophagy. Carcinogenesis. 2021;42(11):1370\u20139.","journal-title":"Carcinogenesis"},{"key":"2415_CR63","doi-asserted-by":"publisher","first-page":"096368972211229","DOI":"10.1177\/09636897221122997","volume":"31","author":"Y Mao","year":"2022","unstructured":"Mao Y, Li W, Weng Y, Hua B, Gu X, Lu C, et al. METTL3-mediated m6A modification of lncRNA MALAT1 facilitates prostate cancer growth by activation of PI3K\/AKT signaling. Cell Transplant. 2022;31: 09636897221122997.","journal-title":"Cell Transplant"},{"issue":"5","key":"2415_CR64","first-page":"2683","volume":"40","author":"XJ Huang","year":"2018","unstructured":"Huang XJ, Xia Y, He GF, Zheng LL, Cai YP, Yin Y, et al. MALAT1 promotes angiogenesis of breast cancer. Oncol Rep. 2018;40(5):2683\u20139.","journal-title":"Oncol Rep"},{"issue":"9","key":"2415_CR65","first-page":"10262","volume":"13","author":"J Shao","year":"2021","unstructured":"Shao J, Zhang Q, Wang P, Wang Z. LncRNA MALAT1 promotes breast cancer progression by sponging miR101-3p to mediate mTOR\/PKM2 signal transmission. Am J Transl Res. 2021;13(9):10262.","journal-title":"Am J Transl Res"},{"issue":"4","key":"2415_CR66","first-page":"714","volume":"9","author":"X Li","year":"2019","unstructured":"Li X, Chen N, Zhou L, Wang C, Wen X, Jia L, et al. Genome-wide target interactome profiling reveals a novel EEF1A1 epigenetic pathway for oncogenic lncRNA MALAT1 in breast cancer. Am J Cancer Res. 2019;9(4):714.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"2415_CR67","doi-asserted-by":"publisher","first-page":"e0198945","DOI":"10.1371\/journal.pone.0198945","volume":"13","author":"SC Eastlack","year":"2018","unstructured":"Eastlack SC, Dong S, Mo YY, Alahari SK. Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer. PLoS One. 2018;13(6):e0198945.","journal-title":"PLoS One"},{"key":"2415_CR68","doi-asserted-by":"publisher","first-page":"658151","DOI":"10.3389\/fonc.2021.658151","volume":"11","author":"CH Shih","year":"2021","unstructured":"Shih CH, Chuang LL, Tsai MH, Chen LH, Chuang EY, Lu TP, et al. Hypoxia-induced MALAT1 promotes the proliferation and migration of breast cancer cells by sponging MiR-3064\u20135p. Front Oncol. 2021;11:658151.","journal-title":"Front Oncol"},{"issue":"1","key":"2415_CR69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41420-024-02058-4","volume":"10","author":"M Dragonetti","year":"2024","unstructured":"Dragonetti M, Turco C, Benedetti A, Goeman F, Forcato M, Scalera S, et al. The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer. Cell Death Discov. 2024;10(1):276.","journal-title":"Cell Death Discov"},{"issue":"46","key":"2415_CR70","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1038\/s41388-024-03171-5","volume":"43","author":"C Zhang","year":"2024","unstructured":"Zhang C, Lu Y-J, Wang M, Chen B, Xiong F, Mitsopoulos C, et al. Characterisation of APOBEC3B-mediated RNA editing in breast cancer cells reveals regulatory roles of NEAT1 and MALAT1 lncRNAs. Oncogene. 2024;43(46):3366\u201377.","journal-title":"Oncogene"},{"issue":"10","key":"2415_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105515","volume":"25","author":"S Wernig-Zorc","year":"2024","unstructured":"Wernig-Zorc S, Schwartz U, Mart\u00ednez-Rodr\u00edguez P, Inalef J, Pavicic F, Ehrenfeld P, et al. The long non-coding RNA MALAT1 modulates NR4A1 expression through a downstream regulatory element in specific cancer cell types. Int J Mol Sci. 2024;25(10): 5515.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2415_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.8132","volume":"46","author":"N Wang","year":"2021","unstructured":"Wang N, Cao S, Wang X, Zhang L, Yuan H, Ma X. LncRNA MALAT1\/miR-26a\/26b\/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines. Oncol Rep. 2021;46(2):1\u201312.","journal-title":"Oncol Rep"},{"issue":"3","key":"2415_CR73","doi-asserted-by":"publisher","first-page":"769","DOI":"10.32604\/biocell.2022.016636","volume":"46","author":"RA Soliman","year":"2022","unstructured":"Soliman RA, Youness RA, Manie TM, Khallaf E, El-Shazly M, Abdelmohsen M, et al. Uncoupling tumor necrosis factor-\u03b1 and interleukin-10 at tumor immune microenvironment of breast cancer through miR-17-5p\/MALAT-1\/H19 circuit. Biocell. 2022;46(3):769.","journal-title":"Biocell"},{"issue":"1","key":"2415_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03539-x","volume":"5","author":"C Turco","year":"2022","unstructured":"Turco C, Esposito G, Iaiza A, Goeman F, Benedetti A, Gallo E, et al. MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. Commun Biol. 2022;5(1):1\u201317.","journal-title":"Commun Biol"},{"issue":"12","key":"2415_CR75","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50(12):1705\u201315.","journal-title":"Nat Genet"},{"issue":"3","key":"2415_CR76","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ijc.31386","volume":"143","author":"ZH Kwok","year":"2018","unstructured":"Kwok ZH, Roche V, Chew XH, Fadieieva A, Tay Y. A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers. Int J Cancer. 2018;143(3):668\u201378.","journal-title":"Int J Cancer"},{"issue":"1","key":"2415_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02113-5","volume":"21","author":"C Zhao","year":"2021","unstructured":"Zhao C, Ling X, Xia Y, Yan B, Guan Q. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1\/miR-26b\/HMGA2 axis. Cancer Cell Int. 2021;21(1):1\u201315.","journal-title":"Cancer Cell Int"},{"issue":"12","key":"2415_CR78","doi-asserted-by":"publisher","first-page":"e23716","DOI":"10.1097\/MD.0000000000023716","volume":"100","author":"M Chen","year":"2021","unstructured":"Chen M, Cai D, Gu H, Yang J, Fan L. MALAT1 rs619586 A\/G polymorphisms are associated with decreased risk of lung cancer. Medicine. 2021;100(12): e23716.","journal-title":"Medicine"},{"issue":"3","key":"2415_CR79","doi-asserted-by":"publisher","first-page":"C649","DOI":"10.1152\/ajpcell.00510.2018","volume":"318","author":"Z-H Hou","year":"2020","unstructured":"Hou Z-H, Xu X-W, Fu X-Y, Zhou L-D, Liu S-P, Tan D-M. Long non-coding RNA MALAT1 promotes angiogenesis and immunosuppressive properties of HCC cells by sponging miR-140. Am J Physiol Cell Physiol. 2020;318(3):C649-63.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"14","key":"2415_CR80","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.7150\/jca.24796","volume":"9","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Tang X, Tian X, Tian J, Zhang Y, Ma J, et al. LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer. J Cancer. 2018;9(14):2436.","journal-title":"J Cancer"},{"issue":"26","key":"2415_CR81","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.7150\/jca.29213","volume":"10","author":"S Liu","year":"2019","unstructured":"Liu S, Qiu J, He G, Liang Y, Wang L, Liu C, et al. LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression. J Cancer. 2019;10(26):6649.","journal-title":"J Cancer"},{"key":"2415_CR82","doi-asserted-by":"crossref","unstructured":"Yu Q, Xiang L, Chen Z, Liu X, Ou H, Zhou J, et al. MALAT1 functions as a competing endogenous RNA to regulate SMAD5 expression by acting as a sponge for miR-142-3p in hepatocellular carcinoma. Cell Biosci. 2019;9(1):39.","DOI":"10.1186\/s13578-019-0299-6"},{"issue":"1","key":"2415_CR83","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12935-023-03034-1","volume":"23","author":"G-Z Li","year":"2023","unstructured":"Li G-Z, Meng G-X, Pan G-Q, Zhang X, Yan L-J, Li R-Z, et al. MALAT1\/mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1\/AMPK signaling pathway. Cancer Cell Int. 2023;23(1):188.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"2415_CR84","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/cells9041020","volume":"9","author":"H-L Chang","year":"2020","unstructured":"Chang H-L, Bamodu OA, Ong J-R, Lee W-H, Yeh C-T, Tsai J-T. Targeting the epigenetic non-coding RNA MALAT1\/Wnt signaling axis as a therapeutic approach to suppress stemness and metastasis in hepatocellular carcinoma. Cells. 2020;9(4): 1020.","journal-title":"Cells"},{"issue":"11","key":"2415_CR85","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1002\/jcb.25862","volume":"118","author":"X Tan","year":"2017","unstructured":"Tan X, Huang Z, Li X. Long non-coding RNA MALAT1 interacts with miR-204 to modulate human hilar cholangiocarcinoma proliferation, migration, and invasion by targeting CXCR4. J Cell Biochem. 2017;118(11):3643\u201353.","journal-title":"J Cell Biochem"},{"issue":"2","key":"2415_CR86","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3892\/mmr.2020.11196","volume":"22","author":"L Zhao","year":"2020","unstructured":"Zhao L, Lou G, Li A, Liu Y. LncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR-375 sponging. Mol Med Rep. 2020;22(2):1449\u201357.","journal-title":"Mol Med Rep"},{"issue":"10","key":"2415_CR87","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-18-1432","volume":"79","author":"P Malakar","year":"2019","unstructured":"Malakar P, Stein I, Saragovi A, Winkler R, Stern-Ginossar N, Berger M, et al. Long noncoding RNA MALAT1 regulates cancer glucose metabolism by enhancing mTOR-mediated translation of TCF7L2. Cancer Res. 2019;79(10):2480\u201393.","journal-title":"Cancer Res"},{"key":"2415_CR88","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.mcpro.2021.100141","volume":"20","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang Y, Guan X, Li X, Zhao Z, Gao Y, et al. An integrated transcriptomics and proteomics analysis implicates lncRNA MALAT1 in the regulation of lipid metabolism. Mol Cell Proteomics. 2021;20:100141.","journal-title":"Mol Cell Proteomics"},{"key":"2415_CR89","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.omtn.2020.09.040","volume":"23","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhou L, Li H, Sun T, Wen X, Li X, et al. Nuclear-encoded lncRNA MALAT1 epigenetically controls metabolic reprogramming in HCC cells through the mitophagy pathway. Molecular Therapy-Nucleic Acids. 2021;23:264\u201376.","journal-title":"Molecular Therapy-Nucleic Acids"},{"issue":"17","key":"2415_CR90","first-page":"3187","volume":"19","author":"L Yang","year":"2015","unstructured":"Yang L, Bai H, Deng Y, Fan L. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015;19(17):3187\u201393.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2415_CR91","doi-asserted-by":"crossref","unstructured":"Hao Y, Yan Z, Zhang A, Hu S, Wang N, Luo XG, et al. IL-6\/STAT3 mediates the HPV18 E6\/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells. Virus Res. 2020;281: 197907.","DOI":"10.1016\/j.virusres.2020.197907"},{"issue":"11","key":"2415_CR92","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1089\/dna.2020.6205","volume":"40","author":"W Tie","year":"2021","unstructured":"Tie W, Ge F. MALAT1 inhibits proliferation of HPV16-positive cervical cancer by sponging miR-485-5p to promote expression of MAT2A. DNA Cell Biol. 2021;40(11):1407\u201317.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"2415_CR93","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s13277-015-3732-4","volume":"37","author":"S Liu","year":"2016","unstructured":"Liu S, Song L, Zeng S, Zhang L. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells. Tumor Biol. 2016;37(1):633\u201340.","journal-title":"Tumor Biol"},{"issue":"6","key":"2415_CR94","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5586","volume":"63","author":"T Liang","year":"2023","unstructured":"Liang T, Lu T, Jia W, Li R, Jiang M, Jiao Y, et al. Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR-124\/SIRT1 axis in cervical cancer cells. Int J Oncol. 2023;63(6): 138.","journal-title":"Int J Oncol"},{"issue":"1","key":"2415_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2016.09.019","volume":"383","author":"Q Li","year":"2016","unstructured":"Li Q, Zhang C, Chen R, Xiong H, Qiu F, Liu S, et al. Disrupting MALAT1\/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett. 2016;383(1):28\u201340.","journal-title":"Cancer Lett"},{"issue":"8","key":"2415_CR96","doi-asserted-by":"publisher","first-page":"8663","DOI":"10.18632\/oncotarget.6675","volume":"7","author":"AE Tee","year":"2016","unstructured":"Tee AE, Liu B, Song R, Li J, Pasquier E, Cheung BB, et al. The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression. Oncotarget. 2016;7(8):8663.","journal-title":"Oncotarget"},{"key":"2415_CR97","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ebiom.2018.12.049","volume":"41","author":"M Zhuang","year":"2019","unstructured":"Zhuang M, Zhao S, Jiang Z, Wang S, Sun P, Quan J, et al. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. EBioMedicine. 2019;41:286\u201398.","journal-title":"EBioMedicine"},{"issue":"4","key":"2415_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03645-4","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Wang X, Zhang T, Su L, Liu B, Zhu Z, et al. Lncrna MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation. Cell Death Dis. 2021;12(4):1\u201317.","journal-title":"Cell Death Dis"},{"key":"2415_CR99","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2147\/CMAR.S243796","volume":"12","author":"Q Dai","year":"2020","unstructured":"Dai Q, Zhang T, Li C. LncRNA MALAT1 regulates the cell proliferation and cisplatin resistance in gastric cancer via PI3K\/AKT pathway. Cancer Manag Res. 2020;12:1929.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"2415_CR100","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12935-017-0408-8","volume":"17","author":"J Li","year":"2017","unstructured":"Li J, Gao J, Tian W, Li Y, Zhang J. Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297. Cancer Cell Int. 2017;17(1):44.","journal-title":"Cancer Cell Int"},{"key":"2415_CR101","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2017.02.035","volume":"395","author":"Y Li","year":"2017","unstructured":"Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N, et al. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis. Cancer Lett. 2017;395:31\u201344.","journal-title":"Cancer Lett"},{"issue":"1","key":"2415_CR102","first-page":"805","volume":"19","author":"G Shao","year":"2020","unstructured":"Shao G, Zhao Z, Zhao W, Hu G, Zhang L, Li W, et al. Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer. Oncol Lett. 2020;19(1):805\u201312.","journal-title":"Oncol Lett"},{"issue":"12","key":"2415_CR103","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/bjc.2016.123","volume":"114","author":"D Meseure","year":"2016","unstructured":"Meseure D, Vacher S, Lallemand F, Alsibai KD, Hatem R, Chemlali W, et al. Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer. Br J Cancer. 2016;114(12):1395\u2013404.","journal-title":"Br J Cancer"},{"issue":"4","key":"2415_CR104","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.3390\/ijms16046677","volume":"16","author":"F Jiao","year":"2015","unstructured":"Jiao F, Hu H, Han T, Yuan C, Wang L, Jin Z, et al. Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci. 2015;16(4):6677\u201393.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2415_CR105","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1158\/1535-7163.MCT-16-0008","volume":"15","author":"L Li","year":"2016","unstructured":"Li L, Chen H, Gao Y, Wang Y-W, Zhang G-Q, Pan S-H, et al. Long noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy. Mol Cancer Ther. 2016;15(9):2232\u201343.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"2415_CR106","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-13-1455","volume":"20","author":"Y Fan","year":"2014","unstructured":"Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, et al. TGF-\u03b2\u2013induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014;20(6):1531\u201341.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2415_CR107","doi-asserted-by":"publisher","first-page":"11219","DOI":"10.1002\/jcp.27772","volume":"234","author":"F Shen","year":"2019","unstructured":"Shen F, Zheng H, Zhou L, Li W, Xu X. Overexpression of MALAT1 contributes to cervical cancer progression by acting as a sponge of miR-429. J Cell Physiol. 2019;234(7):11219\u201326.","journal-title":"J Cell Physiol"},{"issue":"6","key":"2415_CR108","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41419-019-1620-3","volume":"10","author":"F Li","year":"2019","unstructured":"Li F, Li X, Qiao L, Liu W, Xu C, Wang X. MALAT1 regulates miR-34a expression in melanoma cells. Cell Death Dis. 2019;10(6):389.","journal-title":"Cell Death Dis"},{"key":"2415_CR109","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.2147\/CMAR.S249348","volume":"12","author":"P Wang","year":"2020","unstructured":"Wang P, Hu L, Fu G, Lu J, Zheng Y, Li Y, et al. LncRNA MALAT1 promotes the proliferation, migration, and invasion of melanoma cells by downregulating miR-23a. Cancer Manag Res. 2020;12:6553\u201362.","journal-title":"Cancer Manag Res"},{"issue":"9","key":"2415_CR110","first-page":"3939","volume":"8","author":"L Sun","year":"2016","unstructured":"Sun L, Sun P, Zhou QY, Gao X, Han Q. Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140. Am J Transl Res. 2016;8(9):3939\u201346.","journal-title":"Am J Transl Res"},{"issue":"5","key":"2415_CR111","doi-asserted-by":"publisher","first-page":"C903","DOI":"10.1152\/ajpcell.00262.2019","volume":"318","author":"S Wu","year":"2020","unstructured":"Wu S, Chen H, Zuo L, Jiang H, Yan H. Suppression of long noncoding RNA MALAT1 inhibits the development of uveal melanoma via microRNA-608-mediated inhibition of HOXC4. Am J Physiol Cell Physiol. 2020;318(5):C903\u201312.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2415_CR112","doi-asserted-by":"publisher","first-page":"543","DOI":"10.18632\/oncotarget.28447","volume":"14","author":"V Feichtenschlager","year":"2023","unstructured":"Feichtenschlager V, Zheng YJ, Ho W, Chen L, Callanan C, Chen C, et al. Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment. Oncotarget. 2023;14:543\u201360.","journal-title":"Oncotarget"},{"issue":"28","key":"2415_CR113","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm8206","volume":"10","author":"NR Love","year":"2024","unstructured":"Love NR, Williams C, Killingbeck EE, Merleev A, Saffari Doost M, Yu L, et al. Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors. Sci Adv. 2024;10(28): eadm8206.","journal-title":"Sci Adv"},{"issue":"7","key":"2415_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-02795-1","volume":"11","author":"Z-H Chen","year":"2020","unstructured":"Chen Z-H, Chen T-Q, Zeng Z-C, Wang D, Han C, Sun Y-M, et al. Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies. Cell Death Dis. 2020;11(7):1\u201317.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2415_CR115","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/16078454.2020.1867781","volume":"26","author":"X-F Sheng","year":"2021","unstructured":"Sheng X-F, Hong L-L, Li H, Huang F-Y, Wen Q, Zhuang H-F. Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia. Hematology. 2021;26(1):43\u201352.","journal-title":"Hematology"},{"issue":"10","key":"2415_CR116","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/pin.12993","volume":"70","author":"Y Song","year":"2020","unstructured":"Song Y, Guo NH, Zheng JF. LncRNA\u2010MALAT1 regulates proliferation and apoptosis of acute lymphoblastic leukemia cells via miR\u2010205\u2010PTK7 pathway. Pathol Int. 2020;70(10):724\u201332.","journal-title":"Pathol Int"},{"issue":"12","key":"2415_CR117","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1007\/s00277-024-06043-w","volume":"103","author":"S Li","year":"2024","unstructured":"Li S, Gao R, Han X, Wang K, Kang B, Ma X. MALAT1\/miR-582\u20135p\/GALNT1\/MUC1 axis modulates progression of AML leukemia stem cells by regulating JAK2\/STAT3 pathway. Ann Hematol. 2024;103(12):5273\u201383.","journal-title":"Ann Hematol"},{"issue":"1","key":"2415_CR118","first-page":"37","volume":"70","author":"J Jin","year":"2023","unstructured":"Jin J, Fu L, Hong P, Feng W. MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1. Acta Biochim Pol. 2023;70(1):37\u201343.","journal-title":"Acta Biochim Pol"},{"key":"2415_CR119","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2020.06.037","volume":"160","author":"MP Paronetto","year":"2020","unstructured":"Paronetto MP, Dimauro I, Grazioli E, Palombo R, Guidotti F, Fantini C, et al. Exercise-mediated downregulation of MALAT1 expression and implications in primary and secondary cancer prevention. Free Radic Biol Med. 2020;160:28\u201339.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2415_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-1100-9","volume":"14","author":"X Wang","year":"2016","unstructured":"Wang X, Sehgal L, Jain N, Khashab T, Mathur R, Samaniego F. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2. J Transl Med. 2016;14(1):1\u201314.","journal-title":"J Transl Med"},{"issue":"19","key":"2415_CR121","doi-asserted-by":"publisher","first-page":"31305","DOI":"10.18632\/oncotarget.15453","volume":"8","author":"SH Kim","year":"2017","unstructured":"Kim SH, Kim SH, Yang WI, Kim SJ, Yoon SO. Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma. Oncotarget. 2017;8(19):31305.","journal-title":"Oncotarget"},{"issue":"1","key":"2415_CR122","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/ijms23010201","volume":"23","author":"M Fernandes","year":"2022","unstructured":"Fernandes M, Marques H, Teixeira AL, Medeiros R. ceRNA network of lncRNA\/miRNA as circulating prognostic biomarkers in non-hodgkin lymphomas: bioinformatic analysis and assessment of their prognostic value in an NHL cohort. Int J Mol Sci. 2022;23(1):201.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2415_CR123","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41419-024-07209-0","volume":"15","author":"X Bai","year":"2024","unstructured":"Bai X, Li J, Guo X, Huang Y, Xu X, Tan A, et al. LncRNA MALAT1 promotes Erastin-induced ferroptosis in the HBV-infected diffuse large B-cell lymphoma. Cell Death Dis. 2024;15(11):819.","journal-title":"Cell Death Dis"},{"issue":"42","key":"2415_CR124","doi-asserted-by":"publisher","first-page":"29365","DOI":"10.1074\/jbc.M114.572693","volume":"289","author":"B Li","year":"2014","unstructured":"Li B, Chen P, Qu J, Shi L, Zhuang W, Fu J, et al. Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. J Biol Chem. 2014;289(42):29365\u201375.","journal-title":"J Biol Chem"},{"issue":"1","key":"2415_CR125","doi-asserted-by":"publisher","first-page":"2422154","DOI":"10.1080\/16078454.2024.2422154","volume":"29","author":"J Ning","year":"2024","unstructured":"Ning J, Yang R, Wang H, Ma H, Cui L. LncRNA MALAT1 silencing represses CXCL12-induced proliferation, invasion, and homing behavior in multiple myeloma by inhibiting CXCR4. Hematology. 2024;29(1): 2422154.","journal-title":"Hematology"},{"issue":"63","key":"2415_CR126","doi-asserted-by":"publisher","first-page":"106527","DOI":"10.18632\/oncotarget.22507","volume":"8","author":"MA Stamato","year":"2017","unstructured":"Stamato MA, Juli G, Romeo E, Ronchetti D, Arbitrio M, Caracciolo D, et al. Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma. Oncotarget. 2017;8(63): 106527.","journal-title":"Oncotarget"},{"issue":"1","key":"2415_CR127","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1080\/21655979.2021.1920325","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Chi Z, Jin H, Yang W. Microrna miR-188-5p as a mediator of long non-coding RNA MALAT1 regulates cell proliferation and apoptosis in multiple myeloma. Bioengineered. 2021;12(1):1611\u201326.","journal-title":"Bioengineered"},{"issue":"10","key":"2415_CR128","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1002\/jcb.25987","volume":"118","author":"D Gao","year":"2017","unstructured":"Gao D, Lv AE, Li HP, Han DH, Zhang YP. LncRNA MALAT-1 elevates HMGB1 to promote autophagy resulting in inhibition of tumor cell apoptosis in multiple myeloma. J Cell Biochem. 2017;118(10):3341\u20138.","journal-title":"J Cell Biochem"},{"key":"2415_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01562-6","volume":"39","author":"J Xu","year":"2020","unstructured":"Xu J, Xiao Y, Liu B, Pan S, Liu Q, Shan Y, et al. Exosomal MALAT1 sponges miR-26a\/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K\/Akt pathway. J Exp Clin Cancer Res. 2020;39:1\u201315.","journal-title":"J Exp Clin Cancer Res"},{"key":"2415_CR130","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.2147\/CMAR.S242425","volume":"12","author":"F Rong","year":"2020","unstructured":"Rong F, Liu L, Zou C, Zeng J, Xu Y. MALAT1 promotes cell tumorigenicity through regulating miR-515-5p\/EEF2 axis in non-small cell lung cancer. Cancer Manag Res. 2020;12:7691.","journal-title":"Cancer Manag Res"},{"key":"2415_CR131","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/OTT.S155134","volume":"11","author":"P Zhang","year":"2018","unstructured":"Zhang P, Zhou H, Lu K, Lu Y, Wang Y, Feng T. Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer. Onco Targets Ther. 2018;11:291.","journal-title":"Onco Targets Ther"},{"key":"2415_CR132","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5483523","volume":"2022","author":"S Tao","year":"2022","unstructured":"Tao S, Bai Z, Liu Y, Gao Y, Zhou J, Zhang Y, et al. Exosomes derived from tumor cells initiate breast cancer cell metastasis and chemoresistance through a MALAT1-dependent mechanism. J Oncol. 2022;2022: 2022:5483523.","journal-title":"J Oncol"},{"key":"2415_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102076","volume":"49","author":"X Wang","year":"2024","unstructured":"Wang X, Jian Q, Zhang Z, Gu J, Wang X, Wang Y. Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN\/Hippo\/YAP axis. Transl Oncol. 2024;49: 102076.","journal-title":"Transl Oncol"},{"issue":"24","key":"2415_CR134","doi-asserted-by":"publisher","first-page":"e2309298","DOI":"10.1002\/advs.202309298","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu M, et al. M2 tumor-associated macrophages-derived exosomal MALAT1 promotes glycolysis and gastric cancer progression. Adv Sci (Weinh). 2024;11(24): e2309298.","journal-title":"Adv Sci (Weinh)"},{"issue":"25","key":"2415_CR135","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1016\/j.cell.2024.09.024","volume":"187","author":"E You","year":"2024","unstructured":"You E, Danaher P, Lu C, Sun S, Zou L, Phillips IE, et al. Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer. Cell. 2024;187(25):7232-47.e23.","journal-title":"Cell"},{"key":"2415_CR136","doi-asserted-by":"publisher","first-page":"205873841985969","DOI":"10.1177\/2058738419859699","volume":"33","author":"S Wei","year":"2019","unstructured":"Wei S, Wang K, Huang X, Zhao Z, Zhao Z. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p\/programmed death-ligand 1 axis. Int J Immunopathol Pharmacol. 2019;33: 2058738419859699.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2415_CR137","doi-asserted-by":"crossref","unstructured":"Li S, Xie Y, Zhou W, Zhou Q, Tao D, Yang H, et al. Association of long noncoding RNA MALAT1 with the radiosensitivity of lung adenocarcinoma cells via the miR-140\/PD-L1 axis. Heliyon. 2023;9(6):e16868.","DOI":"10.1016\/j.heliyon.2023.e16868"},{"key":"2415_CR138","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7554\/eLife.87900","volume":"12","author":"BD Wheeler","year":"2023","unstructured":"Wheeler BD, Gagnon JD, Zhu WS, Mu\u00f1oz-Sandoval P, Wong SK, Simeonov DS, et al. The lncRNA Malat1 inhibits miR-15\/16 to enhance cytotoxic T cell activation and memory cell formation. Elife. 2023;12:12.","journal-title":"Elife."},{"issue":"96","key":"2415_CR139","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adh5462","volume":"9","author":"E Martinez-Terroba","year":"2024","unstructured":"Martinez-Terroba E, Plasek-Hegde LM, Chiotakakos I, Li V, de Miguel FJ, Robles-Oteiza C, et al. Overexpression of Malat1 drives metastasis through inflammatory reprogramming of the tumor microenvironment. Sci Immunol. 2024;9(96): eadh5462.","journal-title":"Sci Immunol"},{"key":"2415_CR140","doi-asserted-by":"publisher","first-page":"10693","DOI":"10.2147\/OTT.S256669","volume":"Volume 13","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yin Z, Lu P, Ma Y, Luo B, Xiang L, et al. Lung carcinoma cells secrete exosomal MALAT1 to inhibit dendritic cell phagocytosis, inflammatory response, costimulatory molecule expression and promote dendritic cell autophagy via AKT\/mTOR pathway. OncoTargets and therapy. 2020;Volume 13:10693\u2013705.","journal-title":"OncoTargets and therapy."},{"key":"2415_CR141","doi-asserted-by":"publisher","first-page":"S1433","DOI":"10.1016\/j.annonc.2021.10.147","volume":"32","author":"R Youness","year":"2021","unstructured":"Youness R, Gomaa A. 128P Ex-vivo co-blockade of CD-155\/TIGIT and PD-1\/PD-L1 using CCAT-1, H19 and MALAT-1 LncRNAs in hepatocellular carcinoma. Ann Oncol. 2021;32:S1433.","journal-title":"Ann Oncol"},{"key":"2415_CR142","doi-asserted-by":"publisher","first-page":"1004212","DOI":"10.3389\/fonc.2022.1004212","volume":"12","author":"Z Song","year":"2022","unstructured":"Song Z, Wang X, Chen F, Chen Q, Liu W, Yang X, et al. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Front Oncol. 2022;12:1004212.","journal-title":"Front Oncol"},{"key":"2415_CR143","doi-asserted-by":"crossref","unstructured":"Wang Q-M, Lian G-Y, Song Y, Huang Y-F, Gong Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335.","DOI":"10.1016\/j.lfs.2019.03.040"},{"issue":"2","key":"2415_CR144","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s43018-023-00695-9","volume":"5","author":"D Kumar","year":"2024","unstructured":"Kumar D, Gurrapu S, Wang Y, Bae S-Y, Pandey PR, Chen H, et al. LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells. Nat Cancer. 2024;5(2):262\u201382.","journal-title":"Nat Cancer"},{"key":"2415_CR145","doi-asserted-by":"publisher","first-page":"101653","DOI":"10.1016\/j.tranon.2023.101653","volume":"31","author":"RY Mekky","year":"2023","unstructured":"Mekky RY, Ragab MF, Manie T, Attia AA, Youness RA. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer. Transl Oncol. 2023;31:101653.","journal-title":"Transl Oncol"},{"key":"2415_CR146","doi-asserted-by":"publisher","first-page":"1214810","DOI":"10.3389\/fimmu.2023.1214810","volume":"14","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, Naqvi RA, Valverde A, Naqvi AR. LncRNA MALAT1\/microRNA-30b axis regulates macrophage polarization and function. Front Immunol. 2023;14: 1214810.","journal-title":"Front Immunol"},{"issue":"14","key":"2415_CR147","first-page":"3176","volume":"21","author":"Y Jin","year":"2017","unstructured":"Jin Y, Feng S, Qiu S, Shao N, Zheng J. Lncrna MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med Pharmacol Sci. 2017;21(14):3176\u201384.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2415_CR148","first-page":"1853","volume":"24","author":"J Song","year":"2020","unstructured":"Song J, Su Z, Shen Q. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p\/SRSF7 axis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2020;24:1853\u201362.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2415_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104330","volume":"112","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Hafez AA, Taheri M. Metastasis associated lung adenocarcinoma transcript 1: an update on expression pattern and functions in carcinogenesis. Exp Mol Pathol. 2020;112: 104330.","journal-title":"Exp Mol Pathol"},{"issue":"14","key":"2415_CR150","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.7150\/jca.42093","volume":"11","author":"J Gao","year":"2020","unstructured":"Gao J, Wang F, Wu P, Chen Y, Jia Y. Aberrant lncRNA expression in leukemia. J Cancer. 2020;11(14):4284.","journal-title":"J Cancer"},{"issue":"1","key":"2415_CR151","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/s41467-024-46602-3","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Ning J, Teng H, Deng Y, Sheldon M, Shi L, et al. Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis. Nat Commun. 2024;15(1):2384.","journal-title":"Nat Commun"},{"issue":"8","key":"2415_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24556","volume":"36","author":"J Huang","year":"2022","unstructured":"Huang J, Fang J, Chen Q, Chen J, Shen J. Epigenetic silencing of E-cadherin gene induced by lncRNA MALAT-1 in acute myeloid leukaemia. J Clin Lab Anal. 2022;36(8): e24556.","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"2415_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12024","volume":"20","author":"L Xiao","year":"2020","unstructured":"Xiao L, Wang W, Zhao J, Xu H, Li S, Yang X. LncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101\/EZH2 axis in oral squamous cell carcinoma. Oncol Lett. 2020;20(5):1.","journal-title":"Oncol Lett"},{"key":"2415_CR154","doi-asserted-by":"crossref","unstructured":"Liu J, Shi Y, Wu M, Zhang F, Xu M, He Z, et al. JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1. Genes Dis. 2023;10(5):2167\u201378.","DOI":"10.1016\/j.gendis.2022.07.006"},{"key":"2415_CR155","doi-asserted-by":"crossref","unstructured":"Yan H, Gao S, Xu A, Zuo L, Zhang J, Zhao Y, et al. MALAT1 regulates network of microRNA-15a\/16\u2013VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma. Carcinogenesis. 2023;44(10\u201311):760\u201372.","DOI":"10.1093\/carcin\/bgad053"},{"issue":"2","key":"2415_CR156","doi-asserted-by":"publisher","first-page":"pgae011","DOI":"10.1093\/pnasnexus\/pgae011","volume":"3","author":"D Verma","year":"2024","unstructured":"Verma D, Kapoor S, Kumari S, Sharma D, Singh J, Benjamin M, et al. Decoding the genetic symphony: profiling protein-coding and long noncoding RNA expression in T-acute lymphoblastic leukemia for clinical insights. PNAS Nexus. 2024;3(2):pgae011.","journal-title":"PNAS Nexus"},{"issue":"1","key":"2415_CR157","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-018-0606-4","volume":"11","author":"N Amodio","year":"2018","unstructured":"Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, et al. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol. 2018;11(1):63.","journal-title":"J Hematol Oncol"},{"key":"2415_CR158","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.biopha.2017.09.005","volume":"95","author":"Y Zuo","year":"2017","unstructured":"Zuo Y, Li Y, Zhou Z, Ma M, Fu K. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Biomed Pharmacother. 2017;95:922\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2415_CR159","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41420-024-01930-7","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Shao Y, Ren J, Fang Y, Yang B, Lu S, et al. NCAPD3 exerts tumor-promoting effects in prostatic cancer via dual impact on miR-30a-5p by STAT3-MALAT1 and MYC. Cell Death Discov. 2024;10(1):159.","journal-title":"Cell Death Discov"},{"issue":"5","key":"2415_CR160","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1007\/s10528-023-10592-6","volume":"62","author":"M Naveed","year":"2024","unstructured":"Naveed M, Malik A, Anjum H, Ijaz B. LncRNA MALAT1 expression regulates breast cancer progression via PI3K\/AKT\/mTOR pathway modulation. Biochem Genet. 2024;62(5):3421\u201338.","journal-title":"Biochem Genet"},{"key":"2415_CR161","doi-asserted-by":"crossref","unstructured":"Qian Z, Chen L, Wang X, Kan Y, Wang Y, Yu Y, et al. Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma. Clin Exp Med.\u00a02021;22(2):1\u20139.","DOI":"10.1007\/s10238-021-00748-2"},{"key":"2415_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.977266","volume":"12","author":"W Guo","year":"2022","unstructured":"Guo W, Liu GM, Guan JY, Chen YJ, Zhao YZ, Wang K, et al. Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment. Front Oncol. 2022;12: 977266.","journal-title":"Front Oncol"},{"key":"2415_CR163","doi-asserted-by":"crossref","unstructured":"Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, J\u00f6ckel KH, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes. 2013;6:518.","DOI":"10.1186\/1756-0500-6-518"},{"issue":"1","key":"2415_CR164","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/1471-2407-14-809","volume":"14","author":"S-F Cho","year":"2014","unstructured":"Cho S-F, Chang YC, Chang C-S, Lin S-F, Liu Y-C, Hsiao H-H, et al. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer. 2014;14(1): 809.","journal-title":"BMC Cancer"},{"issue":"10","key":"2415_CR165","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","volume":"32","author":"Y Hu","year":"2018","unstructured":"Hu Y, Lin J, Fang H, Fang J, Li C, Chen W, et al. Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Leukemia. 2018;32(10):2250\u201362.","journal-title":"Leukemia"},{"issue":"1","key":"2415_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-021-00497-x","volume":"7","author":"S-J Xie","year":"2021","unstructured":"Xie S-J, Diao L-T, Cai N, Zhang L-T, Xiang S, Jia C-C, et al. mascRNA and its parent lncRNA MALAT1 promote proliferation and metastasis of hepatocellular carcinoma cells by activating ERK\/MAPK signaling pathway. Cell death discovery. 2021;7(1):1\u201314.","journal-title":"Cell death discovery"},{"key":"2415_CR167","doi-asserted-by":"crossref","unstructured":"Tong G, Tong W, He R, Cui Z, Li S, Zhou B, et al. MALAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han population. Int J Med Sci. 2022;19(8):1300.","DOI":"10.7150\/ijms.73026"},{"issue":"6","key":"2415_CR168","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.18632\/aging.204563","volume":"15","author":"T Liu","year":"2023","unstructured":"Liu T, Ma J, Hou D, Wang W, Cao H. Haplotype-GGGT in long non-coding RNA MALAT1 inhibits brain metastatic lung cancer and lymph nodes of lung cancer via the MALAT1\/miR-328\/KATNB1. Aging (Albany NY). 2023;15(6):1918.","journal-title":"Aging (Albany NY)"},{"key":"2415_CR169","first-page":"1","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:1.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2415_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6): 100773.","journal-title":"Transl Oncol"},{"issue":"2","key":"2415_CR171","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128\u201334.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2415_CR172","first-page":"3186","volume":"10","author":"Z Li","year":"2018","unstructured":"Li Z, Xu L, Liu Y, Fu S, Tu J, Hu Y, et al. LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever. American journal of translational research. 2018;10(10):3186.","journal-title":"American journal of translational research"},{"key":"2415_CR173","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gene.2017.11.013","volume":"642","author":"R Peng","year":"2018","unstructured":"Peng R, Luo C, Guo Q, Cao J, Yang Q, Dong K, et al. Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population. Gene. 2018;642:241\u20138.","journal-title":"Gene"},{"issue":"26","key":"2415_CR174","doi-asserted-by":"publisher","first-page":"40418","DOI":"10.18632\/oncotarget.9622","volume":"7","author":"M Jadaliha","year":"2016","unstructured":"Jadaliha M, Zong X, Malakar P, Ray T, Singh DK, Freier SM, et al. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer. Oncotarget. 2016;7(26):40418.","journal-title":"Oncotarget"},{"key":"2415_CR175","first-page":"101592","volume":"37","author":"D Klopotowska","year":"2024","unstructured":"Klopotowska D, Matuszyk J. Downregulation of MALAT1 in triple-negative breast cancer cells. Biochem Biophys Rep. 2024;37:101592.","journal-title":"Biochem Biophys Rep"},{"issue":"8","key":"2415_CR176","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41388-021-02150-4","volume":"41","author":"SC Okpechi","year":"2022","unstructured":"Okpechi SC, Yousefi H, Nguyen K, Cheng T, Alahari NV, Collins-Burow B, et al. Role of Nischarin in the pathology of diseases: a special emphasis on breast cancer. Oncogene. 2022;41(8):1079\u201386.","journal-title":"Oncogene"},{"key":"2415_CR177","doi-asserted-by":"publisher","first-page":"8093949","DOI":"10.1155\/2022\/8093949","volume":"2022","author":"X Wu","year":"2022","unstructured":"Wu X, Tan Y, Tang X. Long noncoding RNA MALAT1 promotes laryngocarcinoma development by targeting miR-708\u20135p\/BRD4 axis to regulate YAP1-mediated epithelial-mesenchymal transition. BioMed research international. 2022;2022:8093949.","journal-title":"BioMed research international"},{"issue":"3","key":"2415_CR178","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/cells14030227","volume":"14","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Tang Y, Fang Z, Wen J, Wicha MS, Luo M. Long non-coding RNAs: key regulators of tumor epithelial\/mesenchymal plasticity and cancer stemness. Cells. 2025;14(3): 227.","journal-title":"Cells"},{"key":"2415_CR179","first-page":"660210 \u2013","volume":"9","author":"ME Hn","year":"2021","unstructured":"Hn ME, Brenner JC, Prince ME, Chinn SB. Advancement in cancer stem cell biology and precision medicine-review article head and neck cancer stem cell plasticity and the tumor microenvironment. Frontiers in Cell and Developmental Biology. 2021;9:660210-.","journal-title":"Frontiers in Cell and Developmental Biology."},{"issue":"1","key":"2415_CR180","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","volume":"24","author":"Y Pan","year":"2025","unstructured":"Pan Y, Yuan C, Zeng C, Sun C, Xia L, Wang G, et al. Cancer stem cells and niches: challenges in immunotherapy resistance. Mol Cancer. 2025;24(1):52.","journal-title":"Mol Cancer"},{"issue":"8","key":"2415_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101134","volume":"14","author":"M Schwerdtfeger","year":"2021","unstructured":"Schwerdtfeger M, Desiderio V, Kobold S, Regad T, Zappavigna S, Caraglia M. Long non-coding RNAs in cancer stem cells. Transl Oncol. 2021;14(8): 101134.","journal-title":"Transl Oncol"},{"key":"2415_CR182","doi-asserted-by":"publisher","first-page":"153783","DOI":"10.1016\/j.prp.2022.153783","volume":"231","author":"F Pouremamali","year":"2022","unstructured":"Pouremamali F, Vahedian V, Hassani N, Mirzaei S, Pouremamali A, Kazemzadeh H, et al. The role of SOX family in cancer stem cell maintenance: with a focus on SOX2. Pathology-Research and Practice. 2022;231: 153783.","journal-title":"Pathology-Research and Practice."},{"key":"2415_CR183","doi-asserted-by":"publisher","first-page":"5417598","DOI":"10.1155\/2020\/5417598","volume":"2020","author":"J Huang","year":"2020","unstructured":"Huang J, Zheng Y, Xiao X, Liu C, Lin J, Zheng S, et al. A circulating long noncoding RNA panel serves as a diagnostic marker for hepatocellular carcinoma. Disease Markers. 2020;2020:5417598.","journal-title":"Disease Markers"},{"issue":"4","key":"2415_CR184","doi-asserted-by":"publisher","first-page":"165432","DOI":"10.1016\/j.bbadis.2019.03.005","volume":"1866","author":"IS Mohiuddin","year":"2020","unstructured":"Mohiuddin IS, Wei S-J, Kang MH. Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2020;1866(4): 165432.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease."},{"key":"2415_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101181","volume":"78","author":"C-J Shi","year":"2025","unstructured":"Shi C-J, Pang F-X, Lei Y-H, Deng L-Q, Pan F-Z, Liang Z-Q, et al. 5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis. Drug Resist Updat. 2025;78: 101181.","journal-title":"Drug Resist Updat"},{"key":"2415_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122394","volume":"338","author":"C Gao","year":"2024","unstructured":"Gao C, Jia K, Fang J, Zhu X, Hu J, Zhang Y, et al. CD95 promotes stemness of colorectal cancer cells by lncRNA MALAT1. Life Sci. 2024;338: 122394.","journal-title":"Life Sci"},{"issue":"14","key":"2415_CR187","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147656","volume":"23","author":"A Siskova","year":"2022","unstructured":"Siskova A, Kral J, Drabova J, Cervena K, Tomasova K, Jungwirth J, et al. Discovery of long non-coding RNA MALAT1 amplification in precancerous colorectal lesions. Int J Mol Sci. 2022;23(14): 7656.","journal-title":"Int J Mol Sci"},{"key":"2415_CR188","doi-asserted-by":"publisher","first-page":"8832541","DOI":"10.1155\/2021\/8832541","volume":"2021","author":"AK Verma","year":"2021","unstructured":"Verma AK, Bharti PS, Rafat S, Bhatt D, Goyal Y, Pandey KK, et al. Autophagy paradox of cancer: role, regulation, and duality. Oxid Med Cell Longev. 2021;2021:8832541.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2415_CR189","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41418-023-01201-5","volume":"32","author":"SP Kolapalli","year":"2025","unstructured":"Kolapalli SP, Nielsen TM, Frankel LB. Post-transcriptional dynamics and RNA homeostasis in autophagy and cancer. Cell Death Differ. 2025;32(1):27\u201336.","journal-title":"Cell Death Differ"},{"issue":"11","key":"2415_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113466","volume":"19","author":"CW Yun","year":"2018","unstructured":"Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci. 2018;19(11): 3466.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2415_CR191","doi-asserted-by":"publisher","first-page":"101124","DOI":"10.3748\/wjg.v31.i11.101124","volume":"31","author":"TV Luong","year":"2025","unstructured":"Luong TV, Cao MTT, Nguyen NVD, Dang HNN, Nguyen TT. Roles of autophagy and long non-coding RNAs in gastric cancer. World J Gastroenterol. 2025;31(11): 101124.","journal-title":"World J Gastroenterol"},{"issue":"42","key":"2415_CR192","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.2174\/0929867328666210521213352","volume":"28","author":"W Xu","year":"2021","unstructured":"Xu W, Ding M, Wang B, Cai Y, Guo C, Yuan C. Molecular mechanism of the canonical oncogenic lncRNA MALAT1 in gastric cancer. Curr Med Chem. 2021;28(42):8800\u20139.","journal-title":"Curr Med Chem"},{"issue":"1","key":"2415_CR193","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-017-0743-3","volume":"16","author":"H YiRen","year":"2017","unstructured":"YiRen H, YingCong Y, Sunwu Y, Keqin L, Xiaochun T, Senrui C, et al. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. Mol Cancer. 2017;16(1):174.","journal-title":"Mol Cancer"},{"key":"2415_CR194","first-page":"1","volume":"62","author":"M Ren","year":"2024","unstructured":"Ren M, Ma H, Guo L, Liu Y, Wang L, Wei S. Single-cell RNA sequencing demonstrates the heterogeneity of different molecular subtypes in gastric cancer. Biochem Genet. 2024;62:1\u201323.","journal-title":"Biochem Genet"},{"issue":"1","key":"2415_CR195","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/CBM-170917","volume":"22","author":"J Ma","year":"2018","unstructured":"Ma J, Wu K, Liu K, Miao R. Effects of MALAT1 on proliferation and apo-ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy. Cancer Biomark. 2018;22(1):63\u201372.","journal-title":"Cancer Biomark"},{"issue":"4","key":"2415_CR196","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12457","volume":"51","author":"X Yu","year":"2018","unstructured":"Yu X, Zheng H, Tse G, Chan MT, Wu WK. Long non-coding RNAs in melanoma. Cell Prolif. 2018;51(4): e12457.","journal-title":"Cell Prolif"},{"issue":"27","key":"2415_CR197","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2305410120","volume":"120","author":"N Zhu","year":"2023","unstructured":"Zhu N, Ahmed M, Li Y, Liao JC, Wong PK. Long noncoding RNA MALAT1 is dynamically regulated in leader cells during collective cancer invasion. Proc Natl Acad Sci U S A. 2023;120(27): e2305410120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2415_CR198","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41419-023-05667-6","volume":"14","author":"Y Duan","year":"2023","unstructured":"Duan Y, Yue K, Ye B, Chen P, Zhang J, He Q, et al. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2. Cell Death Dis. 2023;14(2):149.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2415_CR199","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1007\/s11033-020-05715-w","volume":"47","author":"EO Mahgoub","year":"2020","unstructured":"Mahgoub EO, Razmara E, Bitaraf A, Norouzi F-S, Montazeri M, Behzadi-Andouhjerdi R, et al. Advances of exosome isolation techniques in lung cancer. Mol Biol Rep. 2020;47(9):7229\u201351.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2415_CR200","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri L, Yousefi H, Aref AR, Mohammad Ahadi A, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75.","journal-title":"Mol Cancer"},{"issue":"1","key":"2415_CR201","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-024-02215-4","volume":"24","author":"J Li","year":"2025","unstructured":"Li J, Wang J, Chen Z. Emerging role of exosomes in cancer therapy: progress and challenges. Mol Cancer. 2025;24(1):13.","journal-title":"Mol Cancer"},{"issue":"14","key":"2415_CR202","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.7150\/ijbs.28048","volume":"14","author":"J-J Qiu","year":"2018","unstructured":"Qiu J-J, Lin X-J, Tang X-Y, Zheng T-T, Lin Y-Y, Hua K-Q. Exosomal metastasis-associated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer. Int J Biol Sci. 2018;14(14):1960.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2415_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-04513-5","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang M, Wang J, Wang W. JMJD2C-mediated long non-coding RNA MALAT1\/microRNA-503-5p\/SEPT2 axis worsens non-small cell lung cancer. Cell Death Dis. 2022;13(1):1\u20139.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2415_CR204","first-page":"9443","volume":"15","author":"L Lin","year":"2018","unstructured":"Lin L, Li H, Zhu Y, He S, Ge H. Expression of metastasis-associated lung adenocarcinoma transcript 1 long non-coding RNA in vitro and in patients with non-small cell lung cancer. Oncol Lett. 2018;15(6):9443\u20139.","journal-title":"Oncol Lett"},{"issue":"4","key":"2415_CR205","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/bmm-2021-0930","volume":"16","author":"Z Shi","year":"2022","unstructured":"Shi Z, Huang K, Li Z, Niu Y, Jiang L. Evaluating the expression of tumorigenic long noncoding RNAs in circulating exosomes isolated from non-small-cell lung cancer patients. Biomark Med. 2022;16(4):241\u201351.","journal-title":"Biomark Med"},{"issue":"1","key":"2415_CR206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"SR Kumar","year":"2020","unstructured":"Kumar SR, Kimchi ET, Manjunath Y, Gajagowni S, Stuckel AJ. RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions. Sci Rep. 2020;10(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"1","key":"2415_CR207","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","volume":"7","author":"M Yu","year":"2024","unstructured":"Yu M, Cai Z, Zhang J, Zhang Y, Fu J, Cui X. Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma. Commun Biol. 2024;7(1):1249.","journal-title":"Commun Biol"},{"issue":"2","key":"2415_CR208","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ncrna.2024.01.003","volume":"9","author":"L Hu","year":"2024","unstructured":"Hu L, Xie K, Zheng C, Qiu B, Jiang Z, Luo C, et al. Exosomal MALAT1 promotes the proliferation of esophageal squamous cell carcinoma through glyoxalase 1-dependent methylglyoxal removal. Non-coding RNA Res. 2024;9(2):330\u201340.","journal-title":"Non-coding RNA Res"},{"issue":"8","key":"2415_CR209","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1002\/jcp.26357","volume":"233","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Shan T, Ding W, Hua Z, Shen Y, Lu Z, et al. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling. J Cell Physiol. 2018;233(8):5805\u201314.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2415_CR210","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000477479","volume":"42","author":"Y Xiang","year":"2017","unstructured":"Xiang Y, Zhang Y, Tang Y, Li Q. MALAT1 modulates TGF-\u03b21-induced endothelial-to-mesenchymal transition through downregulation of miR-145. Cell Physiol Biochem. 2017;42(1):357\u201372.","journal-title":"Cell Physiol Biochem"},{"issue":"21","key":"2415_CR211","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.7150\/jca.61194","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang T, Zhang W, Huang W, Hua Z, Li S. LncRNA MALAT1 was regulated by HPV16 E7 independently of pRB in cervical cancer cells. J Cancer. 2021;12(21):6344.","journal-title":"J Cancer"},{"key":"2415_CR212","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/PGPM.S358453","volume":"15","author":"Y Yao","year":"2022","unstructured":"Yao Y, Liang Y, Dong X, Liu S, Zhang S, Liu W, et al. Association of long non-coding RNAs (lncRNAs) ANRIL and MALAT1 polymorphism with cervical cancer. Pharmacogenomics and Personalized Medicine. 2022;15:359.","journal-title":"Pharmacogenomics and Personalized Medicine"},{"issue":"1","key":"2415_CR213","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-025-00771-5","volume":"13","author":"R Miao","year":"2025","unstructured":"Miao R, Wang X, Zhang J, Kang Q, Liu Q, Luo X, et al. Manipulation of cancer cell pyroptosis for therapeutic approaches: challenges and opportunities. Biomark Res. 2025;13(1):58.","journal-title":"Biomark Res"},{"issue":"1","key":"2415_CR214","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"1","key":"2415_CR215","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imm.13871","volume":"174","author":"D Aden","year":"2025","unstructured":"Aden D, Sureka N, Zaheer S, Chaurasia JK, Zaheer S. Metabolic reprogramming in cancer: implications for immunosuppressive microenvironment. Immunology. 2025;174(1):30\u201372.","journal-title":"Immunology"},{"issue":"3","key":"2415_CR216","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00018-018-2946-1","volume":"76","author":"H Liu","year":"2019","unstructured":"Liu H, Luo J, Luan S, He C, Li Z. Long non-coding RNAs involved in cancer metabolic reprogramming. Cell Mol Life Sci. 2019;76(3):495\u2013504.","journal-title":"Cell Mol Life Sci"},{"key":"2415_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00317","volume":"10","author":"X Lin","year":"2020","unstructured":"Lin X, Xiao Z, Chen T, Liang SH, Guo H. Glucose metabolism on tumor plasticity, diagnosis, and treatment. Front Oncol. 2020;10: 317.","journal-title":"Front Oncol"},{"issue":"9","key":"2415_CR218","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1002\/jcp.30311","volume":"236","author":"A Bitaraf","year":"2021","unstructured":"Bitaraf A, Razmara E, Bakhshinejad B, Yousefi H, Vatanmakanian M, Garshasbi M, et al. The oncogenic and tumor suppressive roles of RNA-binding proteins in human cancers. J Cell Physiol. 2021;236(9):6200\u201324.","journal-title":"J Cell Physiol"},{"issue":"11","key":"2415_CR219","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116147","volume":"22","author":"AF Radwan","year":"2021","unstructured":"Radwan AF, Shaker OG, El-Boghdady NA, Senousy MA. Association of MALAT1 and PVT1 variants, expression profiles and target miRNA-101 and miRNA-186 with colorectal cancer: correlation with epithelial-mesenchymal transition. Int J Mol Sci. 2021;22(11): 6147.","journal-title":"Int J Mol Sci"},{"key":"2415_CR220","doi-asserted-by":"publisher","first-page":"8693259","DOI":"10.1155\/2022\/8693259","volume":"2022","author":"X Mu","year":"2022","unstructured":"Mu X, Shen Z, Lin Y, Xiao J, Xia K, Xu C, et al. LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR axis. Oxidative medicine and cellular longevity. 2022;2022:8693259.","journal-title":"Oxidative medicine and cellular longevity"},{"issue":"12","key":"2415_CR221","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.3390\/cancers14122902","volume":"14","author":"S De Martino","year":"2022","unstructured":"De Martino S, Iorio E, Cencioni C, Aiello A, Spallotta F, Chirico M, et al. MALAT1 as a regulator of the androgen-dependent choline kinase A gene in the metabolic rewiring of prostate cancer. Cancers (Basel). 2022;14(12):2902.","journal-title":"Cancers (Basel)"},{"key":"2415_CR222","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez LP, Gomez de Cedron M, Ram\u00edrez de Molina A. Alterations of lipid metabolism in cancer: implications in prognosis and treatment. Front Oncol.\u00a02020;10:577420.","DOI":"10.3389\/fonc.2020.577420"},{"issue":"1","key":"2415_CR223","doi-asserted-by":"publisher","first-page":"e20201606","DOI":"10.1084\/jem.20201606","volume":"218","author":"X Bian","year":"2021","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218(1):e20201606.","journal-title":"J Exp Med"},{"issue":"3","key":"2415_CR224","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","volume":"73","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"2415_CR225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-022-02655-6","volume":"20","author":"D Zhou","year":"2022","unstructured":"Zhou D, Wang Y, Hu H, Liu H, Deng J, Li L, et al. lncRNA MALAT1 promotes HCC metastasis through the peripheral vascular infiltration via miRNA-613: a primary study using contrast ultrasound. World J Surg Oncol. 2022;20(1):1\u201313.","journal-title":"World J Surg Oncol"},{"key":"2415_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103358","volume":"77","author":"YS Lin","year":"2024","unstructured":"Lin YS, Tsai YC, Li CJ, Wei TT, Wang JL, Lin BW, et al. Overexpression of NUDT16L1 sustains proper function of mitochondria and leads to ferroptosis insensitivity in colorectal cancer. Redox Biol. 2024;77: 103358.","journal-title":"Redox Biol"},{"issue":"1","key":"2415_CR227","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12943-025-02255-4","volume":"24","author":"Y Ji","year":"2025","unstructured":"Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W, et al. The epigenetic hallmarks of immune cells in cancer. Mol Cancer. 2025;24(1):66.","journal-title":"Mol Cancer"},{"issue":"2","key":"2415_CR228","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000512326","volume":"88","author":"AM Barbosa","year":"2021","unstructured":"Barbosa AM, Gomes-Gon\u00e7alves A, Castro AG, Torrado E. Immune system efficiency in cancer and the microbiota influence. Pathobiology. 2021;88(2):170\u201386.","journal-title":"Pathobiology"},{"issue":"1","key":"2415_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01406-7","volume":"20","author":"W Jiang","year":"2021","unstructured":"Jiang W, Pan S, Chen X, Wang Z-w, Zhu X. The role of lncRNAs and circRNAs in the PD-1\/PD-L1 pathway in cancer immunotherapy. Mol Cancer. 2021;20(1):1\u201317.","journal-title":"Mol Cancer"},{"issue":"1","key":"2415_CR230","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-023-01925-5","volume":"23","author":"M Chehelgerdi","year":"2024","unstructured":"Chehelgerdi M, Chehelgerdi M, Khorramian-Ghahfarokhi M, Shafieizadeh M, Mahmoudi E, Eskandari F, et al. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy. Mol Cancer. 2024;23(1):9.","journal-title":"Mol Cancer"},{"key":"2415_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114657","volume":"190","author":"YA Uthman","year":"2021","unstructured":"Uthman YA, Ibrahim KG, Abubakar B, Bello MB, Malami I, Imam MU, et al. MALAT1: a promising therapeutic target for the treatment of metastatic colorectal cancer. Biochem Pharmacol. 2021;190: 114657.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2415_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.12854","volume":"22","author":"A Samir","year":"2021","unstructured":"Samir A, Tawab RA, Eltayebi HM. Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes. Oncol Lett. 2021;22(2):1\u201312.","journal-title":"Oncol Lett"},{"issue":"12","key":"2415_CR233","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126388","volume":"23","author":"A Villani","year":"2022","unstructured":"Villani A, Potestio L, Fabbrocini G, Troncone G, Malapelle U, Scalvenzi M. The treatment of advanced melanoma: therapeutic update. Int J Mol Sci. 2022;23(12): 6388.","journal-title":"Int J Mol Sci"},{"key":"2415_CR234","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.742789","volume":"11","author":"S Vimalraj","year":"2021","unstructured":"Vimalraj S, Subramanian R, Dhanasekaran A. LncRNA MALAT1 promotes tumor angiogenesis by regulating MicroRNA-150\u20135p\/VEGFA signaling in osteosarcoma: in-vitro and in-vivo analyses. Front Oncol. 2021;11: 11.","journal-title":"Front Oncol"},{"key":"2415_CR235","unstructured":"Lin X, Huang X, Wang L, Liu W. The long noncoding RNA MALAT1\/microRNA-598\u20133p axis regulates the proliferation and apoptosis of retinoblastoma cells through the PI3K\/AKT pathway.\u00a02022;28:269."},{"issue":"1","key":"2415_CR236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-021-00678-8","volume":"7","author":"S Zhao","year":"2021","unstructured":"Zhao S, Zhang X, Chen S, Zhang S. Long noncoding RNAs: fine-tuners hidden in the cancer signaling network. Cell Death Discov. 2021;7(1):1\u201310.","journal-title":"Cell Death Discov"},{"issue":"10","key":"2415_CR237","doi-asserted-by":"publisher","first-page":"860","DOI":"10.2174\/1568009621666210618164300","volume":"21","author":"C Yang","year":"2021","unstructured":"Yang C, Zhu H, Tan Y, Zhu R, Wu X, Li Y, et al. MALAT1 promotes tumorigenesis and increases cellular sensitivity to herceptin in HER2-positive breast cancer. Curr Cancer Drug Targets. 2021;21(10):860\u20139.","journal-title":"Curr Cancer Drug Targets"},{"key":"2415_CR238","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cancergen.2017.11.005","volume":"220","author":"HE Zidan","year":"2018","unstructured":"Zidan HE, Karam RA, El-Seifi OS, Abd Elrahman TM. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer. Cancer Genet. 2018;220:32\u20137.","journal-title":"Cancer Genet"},{"key":"2415_CR239","doi-asserted-by":"publisher","first-page":"8096764","DOI":"10.1155\/2022\/8096764","volume":"2022","author":"SS Elbasateeny","year":"2022","unstructured":"Elbasateeny SS, Yassin MA, Mokhtar MM, Ismail AM, Ebian HF, Hussein S, et al. Prognostic implications of MALAT1 and BACH1 expression and their correlation with CTCs and Mo-MDSCs in triple negative breast cancer and surgical management options. International Journal of Breast Cancer. 2022;2022:8096764.","journal-title":"International Journal of Breast Cancer"},{"issue":"15","key":"2415_CR240","doi-asserted-by":"publisher","first-page":"e35228","DOI":"10.1016\/j.heliyon.2024.e35228","volume":"10","author":"Z Huanjie","year":"2024","unstructured":"Huanjie Z, Bukhari I, Fazhan L, Wen H, Wang J, Wanqing W, et al. P53-associated lncRNAs regulate immune functions and RNA-modifiers in gastric cancer. Heliyon. 2024;10(15): e35228.","journal-title":"Heliyon"},{"key":"2415_CR241","doi-asserted-by":"publisher","first-page":"107327482412848","DOI":"10.1177\/10732748241284821","volume":"31","author":"H Bao","year":"2024","unstructured":"Bao H, Jiang Y, Wang N, Su H, Han X. Long noncoding RNAs MALAT1 and HOTTIP act as serum biomarkers for hepatocellular carcinoma. Cancer Control. 2024;31: 10732748241284821.","journal-title":"Cancer Control"},{"key":"2415_CR242","doi-asserted-by":"crossref","unstructured":"Li H, Zhang Y, Liu Y, Qu Z, Liu Y, Qi J. Prognostic value of long non-coding RNAs MALAT1 in colorectal cancer patients: a pooled analysis of two cohorts. 2021.","DOI":"10.21203\/rs.3.rs-583663\/v1"},{"key":"2415_CR243","unstructured":"Sun Y, Yan X, Zhu Z, Shen D, Xie Z, Zhao Z, et al. Role of long non-coding RNA MALAT1 in the development and progression of hepatocellular carcinoma. J Clin Hepatol.\u00a02021;12:704\u20138."},{"issue":"7782","key":"2415_CR244","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299\u2013309.","journal-title":"Nature"},{"issue":"3","key":"2415_CR245","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, et al. Drug resistance in cancer: an overview. Cancers. 2014;6(3):1769\u201392.","journal-title":"Cancers"},{"issue":"1","key":"2415_CR246","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12935-024-03510-2","volume":"24","author":"Y Tian","year":"2024","unstructured":"Tian Y, Wang X, Wu C, Qiao J, Jin H, Li H. A protracted war against cancer drug resistance. Cancer Cell Int. 2024;24(1):326.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2415_CR247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01162-0","volume":"19","author":"K Liu","year":"2020","unstructured":"Liu K, Gao L, Ma X, Huang J-J, Chen J, Zeng L, et al. Long non-coding RNAs regulate drug resistance in cancer. Mol Cancer. 2020;19(1):1\u201313.","journal-title":"Mol Cancer"},{"key":"2415_CR248","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2147\/OTT.S196619","volume":"13","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li M, Zhang Z. lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p. Onco Targets Ther. 2020;13:1343.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2415_CR249","first-page":"239","volume":"54","author":"Z Xi","year":"2019","unstructured":"Xi Z, Si J, Nan J. Lncrna MALAT1 potentiates autophagy-associated cisplatin resistance by regulating the microrna-30b\/autophagy-related gene 5 axis in gastric cancer. Int J Oncol. 2019;54(1):239\u201348.","journal-title":"Int J Oncol"},{"key":"2415_CR250","doi-asserted-by":"publisher","first-page":"e922672","DOI":"10.12659\/MSM.922672","volume":"26","author":"J Yu","year":"2020","unstructured":"Yu J, Jin T, Zhang T. Suppression of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) potentiates cell apoptosis and drug sensitivity to taxanes and adriamycin in breast cancer. Med Sci Monit. 2020;26:e922672-81.","journal-title":"Med Sci Monit"},{"issue":"7","key":"2415_CR251","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071918","volume":"12","author":"Y Wu","year":"2020","unstructured":"Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Expression of MALAT1 promotes trastuzumab resistance in HER2 overexpressing breast cancers. Cancers (Basel). 2020;12(7): 1918.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2415_CR252","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41419-025-07657-2","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao X, Li Y, Zhang H, Cai Y, Wang X, Liu Y, et al. Pak5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer. Cell Death Dis. 2025;16(1):323.","journal-title":"Cell Death Dis"},{"issue":"18","key":"2415_CR253","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2217\/pgs-2022-0077","volume":"23","author":"C Shi","year":"2022","unstructured":"Shi C, Ren S, Zhao X, Li Q. LncRNA MALAT1 regulates the resistance of breast cancer cells to paclitaxel via the miR-497\u20135p\/SHOC2 axis. Pharmacogenomics. 2022;23(18):973\u201385.","journal-title":"Pharmacogenomics"},{"issue":"1","key":"2415_CR254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-020-00383-y","volume":"7","author":"H Shaath","year":"2021","unstructured":"Shaath H, Vishnubalaji R, Elango R, Khattak S, Alajez NM. Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy. Cell Death Discov. 2021;7(1):1\u201314.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2415_CR255","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22922","volume":"36","author":"S Li","year":"2021","unstructured":"Li S, Jiang F, Chen F, Deng Y, Pan X. Effect of m6A methyltransferase METTL3\u2010mediated MALAT1\/E2F1\/AGR2 axis on adriamycin resistance in breast cancer. J Biochem Mol Toxicol. 2021;36(1): e22922.","journal-title":"J Biochem Mol Toxicol"},{"key":"2415_CR256","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108720","volume":"112","author":"N Hu","year":"2019","unstructured":"Hu N, Chen L, Wang C, Zhao H. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells. Biomed Pharmacother. 2019;112: 108720.","journal-title":"Biomed Pharmacother"},{"key":"2415_CR257","doi-asserted-by":"publisher","first-page":"204062232199725","DOI":"10.1177\/2040622321997259","volume":"12","author":"L Xue","year":"2021","unstructured":"Xue L, Li C, Ren J, Wang Y. KDM4C contributes to cytarabine resistance in acute myeloid leukemia via regulating the miR-328-3p\/CCND2 axis through MALAT1. Therapeutic Advances in Chronic Disease. 2021;12: 2040622321997259.","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"2415_CR258","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gene.2019.01.003","volume":"692","author":"S Pouyanrad","year":"2019","unstructured":"Pouyanrad S, Rahgozar S, Ghodousi ES. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia. Gene. 2019;692:35\u201343.","journal-title":"Gene"},{"issue":"1","key":"2415_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01549-5","volume":"20","author":"C Fan","year":"2020","unstructured":"Fan C, Yuan Q, Liu G, Zhang Y, Yan M, Sun Q, et al. Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p\/ADAM17 axis in colorectal cancer cells. Cancer Cell Int. 2020;20(1):1\u201312.","journal-title":"Cancer Cell Int"},{"key":"2415_CR260","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.2147\/IJGM.S393270","volume":"15","author":"W Shen","year":"2022","unstructured":"Shen W, Yu Q, Pu Y, Xing C. Upregulation of long noncoding RNA MALAT1 in colorectal cancer promotes radioresistance and aggressive malignance. Int J Gen Med. 2022;15:8365\u201380.","journal-title":"Int J Gen Med"},{"issue":"1","key":"2415_CR261","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11010-020-03904-6","volume":"476","author":"Y Cao","year":"2021","unstructured":"Cao Y, Zhang F, Wang H, Bi C, Cui J, Liu F, et al. Lncrna MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129\u20135p\/Nova1 axis. Mol Cell Biochem. 2021;476(1):279\u201392.","journal-title":"Mol Cell Biochem"},{"key":"2415_CR262","unstructured":"Wang N, Hou M, Zhan Y, Shen X, Xue H. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K\/AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22(22):7653\u20139."},{"key":"2415_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110326","volume":"94","author":"W Chen","year":"2022","unstructured":"Chen W, Tan X, Yang Q, Fang Z, Xu Y. MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p\/PBOV1 axis. Cell Signal. 2022;94: 110326.","journal-title":"Cell Signal"},{"issue":"1","key":"2415_CR264","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01133-7","volume":"15","author":"J Luo","year":"2024","unstructured":"Luo J, Ren Q, Liu X, Zheng Q, Yang L, Meng M, et al. Lncrna MALAT-1 modulates EGFR-TKI resistance in lung adenocarcinoma cells by downregulating miR-125. Discover Oncol. 2024;15(1): 379.","journal-title":"Discover Oncol"},{"key":"2415_CR265","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.biopha.2018.02.130","volume":"101","author":"Z Fang","year":"2018","unstructured":"Fang Z, Chen W, Yuan Z, Liu X, Jiang H. Lncrna-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation. Biomed Pharmacother. 2018;101:536\u201342.","journal-title":"Biomed Pharmacother"},{"key":"2415_CR266","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.2147\/OTT.S251518","volume":"13","author":"R Wang","year":"2020","unstructured":"Wang R, Lu X, Yu R. LncRNA MALAT1 promotes EMT process and cisplatin resistance of oral squamous cell carcinoma via PI3K\/AKT\/m-TOR signal pathway. Onco Targets Ther. 2020;13:4049\u201361.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"2415_CR267","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/cancers14030749","volume":"14","author":"M Marhold","year":"2022","unstructured":"Marhold M, Udovica S, Topakian T, Horak P, Horvat R, Tomasich E, et al. MALAT1 fusions and basal cells contribute to primary resistance against androgen receptor inhibition in TRAMP mice. Cancers. 2022;14(3):749.","journal-title":"Cancers"},{"key":"2415_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123663","volume":"373","author":"L Li","year":"2025","unstructured":"Li L, Zhang J, Li H, Qin L, Wu H, Li Z, et al. Targeted inhibition of JMJD2C\/MALAT1 axis compensates for the deficiency of metformin in reversing ovarian cancer platinum resistance. Life Sci. 2025;373: 123663.","journal-title":"Life Sci"},{"issue":"7","key":"2415_CR269","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrc2402","volume":"8","author":"C Kumar-Sinha","year":"2008","unstructured":"Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer. 2008;8(7):497\u2013511.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2415_CR270","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/iub.2888","volume":"76","author":"M Ebrahimnezhad","year":"2024","unstructured":"Ebrahimnezhad M, Asl SH, Rezaie M, Molavand M, Yousefi B, Majidinia M. LncRNAs: new players of cancer drug resistance via targeting ABC transporters. IUBMB Life. 2024;76(11):883\u2013921.","journal-title":"IUBMB Life"},{"issue":"1","key":"2415_CR271","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ncrna.2023.10.008","volume":"9","author":"S Gupta","year":"2024","unstructured":"Gupta S, Silveira DA, Piedade GPS, Ostrowski MP, Mombach JCM, Hashimoto RF. A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer. Noncoding RNA Res. 2024;9(1):185\u201393.","journal-title":"Noncoding RNA Res"},{"issue":"12","key":"2415_CR272","doi-asserted-by":"publisher","first-page":"11243","DOI":"10.1007\/s11033-022-07680-y","volume":"49","author":"S Ak Aksoy","year":"2022","unstructured":"Ak Aksoy S, Tunca B, Er\u00e7elik M, Tezcan G, Ozturk E, Cecener G, et al. Early-stage colon cancer with high MALAT1 expression is associated with the 5-fluorouracil resistance and future metastasis. Mol Biol Rep. 2022;49(12):11243\u201353.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"2415_CR273","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","volume":"25","author":"M Coan","year":"2024","unstructured":"Coan M, Haefliger S, Ounzain S, Johnson R. Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet. 2024;25(8):578\u201395.","journal-title":"Nat Rev Genet"},{"issue":"8","key":"2415_CR274","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021;20(8):629\u201351.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2415_CR275","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.eururo.2017.04.005","volume":"72","author":"R Wang","year":"2017","unstructured":"Wang R, Sun Y, Li L, Niu Y, Lin W, Lin C, et al. Preclinical study using Malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9\u00ae to suppress enzalutamide-resistant prostate cancer progression. Eur Urol. 2017;72(5):835\u201344.","journal-title":"Eur Urol"},{"issue":"4","key":"2415_CR276","first-page":"1245","volume":"43","author":"X Jiang","year":"2020","unstructured":"Jiang X, Li D, Wang G, Liu J, Su X, Yu W, et al. Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1. Oncol Rep. 2020;43(4):1245\u201355.","journal-title":"Oncol Rep"},{"issue":"9","key":"2415_CR277","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","volume":"32","author":"N Amodio","year":"2018","unstructured":"Amodio N, Stamato MA, Juli G, Morelli E, Fulciniti M, Manzoni M, et al. Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. Leukemia. 2018;32(9):1948\u201357.","journal-title":"Leukemia"},{"issue":"1","key":"2415_CR278","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1021\/acsami.8b18288","volume":"11","author":"N Gong","year":"2018","unstructured":"Gong N, Teng X, Li J, Liang X-J. Antisense oligonucleotide-conjugated nanostructure-targeting lncRNA MALAT1 inhibits cancer metastasis. ACS Appl Mater Interfaces. 2018;11(1):37\u201342.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"2415_CR279","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/2326-6066.CIR-23-0045","volume":"11","author":"O Adewunmi","year":"2023","unstructured":"Adewunmi O, Shen Y, Zhang XH, Rosen JM. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer. Cancer Immunol Res. 2023;11(11):1462\u201379.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"2415_CR280","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/acschembio.8b00807","volume":"14","author":"FA Abulwerdi","year":"2019","unstructured":"Abulwerdi FA, Xu W, Ageeli AA, Yonkunas MJ, Arun G, Nam H, et al. Selective small-molecule targeting of a triple helix encoded by the long noncoding RNA, MALAT1. ACS Chem Biol. 2019;14(2):223\u201335.","journal-title":"ACS Chem Biol"},{"key":"2415_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110209","volume":"127","author":"J He","year":"2020","unstructured":"He J, Huang B, Zhang K, Liu M, Xu T. Long non-coding RNA in cervical cancer: from biology to therapeutic opportunity. Biomed Pharmacother. 2020;127: 110209.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"2415_CR282","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/2767-9764.CRC-23-0089","volume":"3","author":"A Yadav","year":"2023","unstructured":"Yadav A, Biswas T, Praveen A, Ganguly P, Bhattacharyya A, Verma A, et al. Targeting MALAT1 augments sensitivity to PARP inhibition by impairing homologous recombination in prostate cancer. Cancer Res Commun. 2023;3(10):2044\u201361.","journal-title":"Cancer Res Commun"},{"issue":"1","key":"2415_CR283","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-022-00252-3","volume":"44","author":"S Ahmadi-Balootaki","year":"2022","unstructured":"Ahmadi-Balootaki S, Doosti A, Jafarinia M, Goodarzi HR. Targeting the MALAT1 gene with the CRISPR\/Cas9 technique in prostate cancer. Genes Environ. 2022;44(1): 22.","journal-title":"Genes Environ"},{"issue":"1","key":"2415_CR284","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01743-5","volume":"21","author":"B Zhu","year":"2021","unstructured":"Zhu B, Cui H, Xu W. Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1\/miR-124-3p\/EZH2 axis. Cancer Cell Int. 2021;21(1):1\u201310.","journal-title":"Cancer Cell Int"},{"key":"2415_CR285","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2147\/CMAR.S241093","volume":"12","author":"X Lu","year":"2020","unstructured":"Lu X, Chen D, Yang F, Xing N. Quercetin inhibits epithelial-to-mesenchymal transition (EMT) process and promotes apoptosis in prostate cancer via downregulating lncRNA MALAT1. Cancer Manag Res. 2020;12:1741.","journal-title":"Cancer Manag Res"},{"key":"2415_CR286","doi-asserted-by":"crossref","unstructured":"Abdel-Latif M, Riad A, Soliman RA, Elkhouly A, Nafae H, Gad MZ, et al. MALAT-1\/p53\/miR-155\/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer. Molecular and Cellular Biochemistry. 2021;477(4):1281-93","DOI":"10.1007\/s11010-022-04378-4"},{"issue":"15","key":"2415_CR287","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1111\/jcmm.16742","volume":"25","author":"Y Huang","year":"2021","unstructured":"Huang Y, Zhou Z, Zhang J, Hao Z, He Y, Wu Z, et al. LncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell. J Cell Mol Med. 2021;25(15):7135\u201345.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2415_CR288","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.joim.2024.11.003","volume":"23","author":"CY Feng","year":"2025","unstructured":"Feng CY, Cai CS, Shi XQ, Zhang ZJ, Su D, Qiu YQ. Resveratrol promotes mitophagy via the MALAT1\/miR-143-3p\/RRM2 axis and suppresses cancer progression in hepatocellular carcinoma. J Integr Med. 2025;23(1):79\u201392.","journal-title":"J Integr Med"},{"issue":"2","key":"2415_CR289","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/nar\/gkv1206","volume":"44","author":"KA Lennox","year":"2016","unstructured":"Lennox KA, Behlke MA. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res. 2016;44(2):863\u201377.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"2415_CR290","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.1093\/nar\/gkaa585","volume":"48","author":"A Donlic","year":"2020","unstructured":"Donlic A, Zafferani M, Padroni G, Puri M, Hargrove AE. Regulation of MALAT1 triple helix stability and in vitro degradation by diphenylfurans. Nucleic Acids Res. 2020;48(14):7653\u201364.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2415_CR291","first-page":"e12","volume":"45","author":"A Goyal","year":"2017","unstructured":"Goyal A, Myacheva K, Gro\u00df M, Klingenberg M, Duran Arqu\u00e9 B, Diederichs S. Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes. Nucleic Acids Res. 2017;45(3):e12-e.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2415_CR292","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","volume":"24","author":"G Arun","year":"2018","unstructured":"Arun G, Diermeier SD, Spector DL. Therapeutic targeting of long non-coding RNAs in cancer. Trends Mol Med. 2018;24(3):257\u201377.","journal-title":"Trends Mol Med"},{"issue":"3","key":"2415_CR293","volume":"35","author":"B Dume","year":"2024","unstructured":"Dume B, Licarete E, Banciu M. Advancing cancer treatments: the role of oligonucleotide-based therapies in driving progress. Mol Ther. 2024;35(3): 102256.","journal-title":"Mol Ther"},{"issue":"6","key":"2415_CR294","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrd4018","volume":"12","author":"C Wahlestedt","year":"2013","unstructured":"Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013;12(6):433\u201346.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2415_CR295","first-page":"79","volume":"7","author":"J Hazan","year":"2021","unstructured":"Hazan J, Bester AC. CRISPR-based approaches for the high-throughput characterization of long non-coding RNAs. Noncoding RNA. 2021;7(4):79.","journal-title":"Noncoding RNA"},{"issue":"1","key":"2415_CR296","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12943-023-01798-8","volume":"22","author":"P Kesharwani","year":"2023","unstructured":"Kesharwani P, Ma R, Sang L, Fatima M, Sheikh A, Abourehab MAS, et al. Gold nanoparticles and gold nanorods in the landscape of cancer therapy. Mol Cancer. 2023;22(1):98.","journal-title":"Mol Cancer"},{"issue":"7","key":"2415_CR297","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41556-024-01448-1","volume":"26","author":"G Qin","year":"2024","unstructured":"Qin G, Liu Z, Yang J, Liao X, Zhao C, Ren J, et al. Targeting specific DNA G-quadruplexes with CRISPR-guided G-quadruplex-binding proteins and ligands. Nat Cell Biol. 2024;26(7):1212\u201324.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2415_CR298","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/odi.14730","volume":"30","author":"R Shalaby","year":"2024","unstructured":"Shalaby R, Ibrahim S, Kotb AAW, Baz S, Hafed L, Shaker O, et al. MALAT1 as a potential salivary biomarker in oral squamous cell carcinoma through targeting miRNA-124. Oral Dis. 2024;30(4):2075\u201383.","journal-title":"Oral Dis"},{"issue":"7","key":"2415_CR299","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073295","volume":"22","author":"H Xiong","year":"2021","unstructured":"Xiong H, Veedu RN, Diermeier SD. Recent advances in oligonucleotide therapeutics in oncology. Int J Mol Sci. 2021;22(7): 3295.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2415_CR300","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.ymthe.2025.02.045","volume":"33","author":"V DeFranciscis","year":"2025","unstructured":"DeFranciscis V, Amabile G, Kortylewski M. Clinical applications of oligonucleotides for cancer therapy. Mol Ther. 2025;33(6):2705\u201318.","journal-title":"Mol Ther"},{"issue":"1","key":"2415_CR301","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1): 71.","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"2415_CR302","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1002\/jcb.27769","volume":"120","author":"D Xia","year":"2019","unstructured":"Xia D, Sui R, Zhang Z. Administration of resveratrol improved Parkinson\u2019s disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1\/miR-129\/SNCA signaling pathway. J Cell Biochem. 2019;120(4):4942\u201351.","journal-title":"J Cell Biochem"},{"issue":"2","key":"2415_CR303","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li Z, Chen X, Zhang S. Long non-coding RNAs: from disease code to drug role. Acta Pharm Sin B. 2020;11(2):340\u201354.","journal-title":"Acta Pharm Sin B"},{"key":"2415_CR304","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115481","volume":"216","author":"L Dykman","year":"2025","unstructured":"Dykman L, Khlebtsov B, Khlebtsov N. Drug delivery using gold nanoparticles. Adv Drug Deliv Rev. 2025;216: 115481.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02415-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:07:05Z","timestamp":1759759625000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02415-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":304,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2415"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02415-6","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}